Ideas

December 5, 2017

Published by admin_auro at December 5, 2017

Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: Rosiglitazone(Brand name: Avantia), an anti-hyperglycemic medication, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 6/December/2017, 12.24 am

Introduction: What they say A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]

December 5, 2017

Published by admin_auro at December 5, 2017

Categories

Molecular therapy for heart regeneration and repair: Agomelatine (brand names: Valdoxan, Melitor, Thymanax), an antidepressant, increases Agrin expression, activates Yap and ERK-mediated signaling, replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 5/December/2017, 11.59 pm

Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, […]

December 5, 2017

Published by admin_auro at December 5, 2017

Categories

Molecular therapy for Cardiomyopathy: Tetramethylpyrazine nitrone (TBN), a neuroprotective drug candidate for stroke, decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 5/December/2017, 11.55 pm

Introduction: What they say A recent study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]

December 5, 2017

Published by admin_auro at December 5, 2017

Categories

Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: Agmatine (4-Aminobutyl guanidine), a neurotransmitter, increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 5/December/2017, 11.51 pm

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]